Skip to main content
Journal ArticleOPEN ACCESS

Voriconazole - A new therapeutic agent with an extended spectrum of antifungal activity

Clinical Microbiology and Infection (2004) 10(SUPPL. 1) 107-117
DOI: 10.1111/j.1470-9465.2004.00838.x
102Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Voriconazole is a new antifungal agent that can be given orally and intravenously. It has proven efficacy for treating candidosis and invasive aspergillosis as well as other mould infections, such as those caused by Fusarium and Scedosporium spp. The drug is generally well tolerated. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.

Author supplied keywords

Cite

CITATION STYLE

APA

Donnelly, J. P., & De Pauw, B. E. (2004). Voriconazole - A new therapeutic agent with an extended spectrum of antifungal activity. Clinical Microbiology and Infection, 10(SUPPL. 1), 107–117. https://doi.org/10.1111/j.1470-9465.2004.00838.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free